Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 56,258 | 52,590 | 50,041 | 53,185 | 47,651 |
| Cost of Goods | 2,954 | 2,736 | 3,521 | 2,590 | 2,551 |
| Gross Profit | 53,304 | 49,854 | 46,520 | 50,595 | 45,100 |
| Operating Expenses | 85,542 | 89,093 | 88,069 | 61,464 | 56,651 |
| Operating Income | -31,284 | -38,503 | -41,028 | -10,279 | -11,000 |
| Other Income | 2,894 | 3,616 | 3,660 | 3,782 | 4,756 |
| Pre-tax Income | -28,390 | -34,887 | -37,368 | -6,497 | -6,244 |
| Income Tax | -5,804 | -7,680 | -7,874 | -1,585 | -920 |
| Net Income Continuous | -22,586 | -27,207 | -29,494 | -4,912 | -5,324 |
| Net Income | $-22,586 | $-27,207 | $-29,494 | $-4,912 | $-5,324 |
| EPS Basic Total Ops | -0.38 | -0.46 | -0.50 | -0.09 | -0.09 |
| EPS Basic Continuous Ops | -0.38 | -0.46 | -0.50 | -0.08 | -0.09 |
| EPS Diluted Total Ops | -0.38 | -0.46 | -0.50 | -0.09 | -0.09 |
| EPS Diluted Continuous Ops | -0.38 | -0.46 | -0.50 | -0.08 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.46 | -0.50 | -0.08 | -0.09 |
| EBITDA(a) | $-29,726 | $-37,038 | $-39,794 | $-9,821 | $-11,010 |